Skip to content
naulon
Not checkedNot checked for notices yet.

RELATIVE DOSING OF PHOSPHATE BINDERS FOR EFFECTIVE MANAGEMENT OF PHOSPHATE AND PROTEIN INTAKE IN CHRONIC KIDNEY DISEASE

J Brian Copley, Jamie Heise

Kidney Research and Clinical Practice · 2012

doi:10.1016/j.krcp.2012.04.623 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Patients with chronic kidney disease undergoing haemodialysis have a maximum recommended dietary phosphate (P) intake of 1000 mg/day and a recommended protein intake of 1.2 g/kg/day. Achieving this level of protein intake is associated with the best patient outcomes. However, protein-containing foods also contain P, and elevated serum P is associated with increased all-cause mortality. It is therefore important to manage the levels of serum P while maintaining adequate levels of nutrition. For different P binders, we estimated the dose and associated tablet burden needed to remove excess P based on the maximum recommended daily P intake. We also examined the implications for patient nutrition. Published binding capacities of different P binders in healthy volunteers ingesting up to 2000 mg/day P, are in the range of 26–135 mg P/g binder. Assuming that 60% of ingested P is absorbed, and that haemodialysis three-times weekly will remove 2400 mg P, a haemodialysis patient ingesting 1000 mg/day P will have a residual P burden of 257 mg/day. To bind this, patients would require a maximum of 3 x 1000 mg lanthanum carbonate tablets, or approximately 9 x 400 mg calcium carbonate tablets, or approximately 9 x 800 mg sevelamer hydrochloride tablets. The recommended protein intake for a 70 kg haemodialysis patient is 84 g/day. A realistic estimate of the average P content of a typical diet is 15 mg/g protein, which equates to a P intake of 1260 mg/day. This is considerably in excess of the recommended limit and, depending on vitamin D status more than 60% may be absorbed, further adding to the residual P burden. The availability of binding capacity data for P binders, presents physicians with the possibility of tailoring doses of binder to a patient’s diet, facilitating sufficient intake of dietary protein while maintaining a neutral P balance. Use of high-capacity binders, such as lanthanum carbonate, would minimize the tablet burden faced by patients and this may also encourage adherence.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.